NDRG2 and lymphoma: NDRG2 is capable of activating PTEN by dephosphorylating the serine-threonine cluster, and loss of NDRG2 decreases the functionality of PTEN and subsequently activates the PI3K-Akt pathway in adult T-cell leukemia-lymphoma [66].